Cargando…
Optimizing methotrexate withdrawal during COVID vaccination
Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524381/ https://www.ncbi.nlm.nih.gov/pubmed/36180548 http://dx.doi.org/10.1038/s41584-022-00856-7 |